United Therapeutics Corp (UTHR): Capital Expenditures
$520.50M
Year ended 2025-12-31
$592.20M
Trailing 12 months to 2026-06-30
+55.4%
3-year compound annual growth
+54.4%
5-year compound annual growth
+26.5%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $520.50M | +111.2% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $246.50M | +7.0% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $230.40M | +66.0% | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | $138.80M | +14.9% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $120.80M | +103.7% | 2024-02-21, From 2021-01-01 |
| 2020-12-31 | $59.30M | -29.2% | 2023-02-22, From 2020-01-01 |
| 2019-12-31 | $83.70M | -54.6% | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $184.40M | +113.7% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $86.30M | +127.1% | 2020-02-26, From 2017-01-01 |
| 2016-12-31 | $38.00M | -23.7% | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $49.80M | +5.1% | 2018-02-21, From 2015-01-01 |
| 2014-12-31 | $47.40M | +48.5% | 2017-02-22, From 2014-01-01 |
| 2013-12-31 | $31.91M | -71.5% | 2016-02-25, From 2013-01-01 |
| 2012-12-31 | $111.91M | +211.0% | 2015-02-24, From 2012-01-01 |
| 2011-12-31 | $35.98M | +93.0% | 2014-02-25, From 2011-01-01 |
| 2010-12-31 | $18.64M | -80.5% | 2013-02-26, From 2010-01-01 |
| 2009-12-31 | $95.40M | -23.3% | 2012-02-28, From 2009-01-01 |
| 2008-12-31 | $124.42M | n/a | 2011-02-24, From 2008-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| United Therapeutics Corp (UTHR) | 2025-12-31 | $520.50M | +111.2% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $103.04M | +20.6% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $70.06M | +34.9% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $58.70M | +71.2% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $93.40M | -21.0% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $58.75M | +54.3% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $101.97M | -25.5% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $276.00M | +87.8% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $185.84M | -62.3% |
Compare UTHR, BMRN, AMRX, ALNY side by side · Screen every company in Pharmaceutical Preparations ↗